Mannose-binding lectin: do we need it?
Mannose-binding lectin (MBL) deficiency has now been recognised for 15 years. Numerous studies have shown that MBL deficiency is associated with an increased susceptibility to a range of infections. However, the importance of MBL, in defence against infection, is still debated. This article discusses recent developments in MBL research and explores how MBL may be operating in the setting of modern medical practice.
Klein
N J
NJ
Infectious Diseases and Microbiology Unit, Institute of Child Health, 30 Guilford Street, London WC1N 1EH, UK. n.klein@ich.ucl.ac.uk
D000818:Animals; D006678:HIV / Q000276:immunology; D006801:Humans; D007249:Inflammation / Q000276:immunology; D037601:Mannose-Binding Lectin / Q000172:deficiency* / Q000276:immunology / Q000502:physiology*; D009503:Neutropenia / Q000276:immunology
D037601:Mannose-Binding Lectin